COMMUNIQUÉS West-GlobeNewswire

Monopar Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
14/05/2026
WILMETTE, Ill., May 14, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company developing innovative treatments for patients with unmet [...]
Historical DNA connects 1.3 million living relatives to 17th-century Maryland settlers and may have identified the colony’s second governor
14/05/2026
Analysis of Historic St. Mary’s City highlights the power of combining ancient DNA, archaeology, and genealogy to restore lost identities and track the migrations of America's earliest English colonists and their [...]
Award-Winning Film ‘An Inconvenient Study’ Being Blocked By Verizon
14/05/2026
ICAN Investigates Reports That Verizon Customers Are Unable to Access AnInconvenientStudy.com AUSTIN, Texas, May 14, 2026 (GLOBE NEWSWIRE) -- Informed Consent Action Network (ICAN) is investigating mounting reports from [...]
Adaptin Bio Shares (Ticker: APTN) Commence Trading on the OTCQB
14/05/2026
CHARLOTTE, N.C., May 14, 2026 (GLOBE NEWSWIRE) -- Adaptin Bio , Inc. (OTCQB: APTN), (“Adaptin” or the “Company”), a biotechnology company developing precision cancer therapeutics enabled by targeted delivery to the [...]
AdCare Rhode Island Among Few in the Northeast Offering Accelerated Methadone Detox
14/05/2026
NORTH KINGSTOWN, R.I., May 14, 2026 (GLOBE NEWSWIRE) -- AdCare Rhode Island, a leading provider of addiction treatment services, is among a select group of facilities in the Northeast offering an accelerated methadone [...]
Inner Voyage Recovery Center launches virtual intensive outpatient program for Georgia and beyond
14/05/2026
Woodstock rehab brings structured addiction treatment to patients who can't access in-person treatment — wherever they are. Woodstock, GA, May 14, 2026 (GLOBE NEWSWIRE) -- Inner Voyage Recovery Center, a leading drug [...]
Terumo Neuro Announces Publication of Landmark RAGE Study Results for HydroCoil™ Embolic System Coils for Ruptured Intracranial Aneurysms
14/05/2026
Largest prospective, core lab–adjudicated trial in North America confirms strong occlusion, low rebleeding, and favorable functional independence Aliso Viejo, CA, May 14, 2026 (GLOBE NEWSWIRE) -- Terumo Neuro, a global [...]
Tessera Therapeutics Showcases New Preclinical Data Advancing In Vivo Program in Sickle Cell Disease and CAR-T Applications at the American Society of Gene and Cell Therapy 29th Annual Meeting
14/05/2026
Presented improved editing data in non-human primates (NHP) for sickle cell disease (SCD), demonstrating a single dose of Gene Writer achieved an average of 85% of long-term hematopoietic stem cells (LT-HSCs) with at [...]
Red Ribbon Recovery Colorado now offers virtual addiction treatment to patients across the United States
14/05/2026
Addiction and mental health treatment, delivered virtually across the U.S. Louisville, CO, May 14, 2026 (GLOBE NEWSWIRE) -- Red Ribbon Recovery Colorado is now providing virtual mental health and addiction treatment to [...]
DentPrime Introduces an “International Complication Protection Program” for Overseas Dental Patients
14/05/2026
New initiative to increase patient confidence and long-term aftercare support in international dental treatment ANTALYA, Türkiye, May 14, 2026 (GLOBE NEWSWIRE) -- As dental tourism grows internationally for patients [...]
Lanier Recovery Center opens its doors in Suwanee, Georgia, bringing comprehensive addiction treatment to the Atlanta region
14/05/2026
Lanier Recovery Center opens in Suwanee to give Atlanta-area individuals and families a trusted local resource for addiction treatment and mental health care. Suwanee, GA, May 14, 2026 (GLOBE NEWSWIRE) -- Lanier [...]
NFL Hall of Famer Brett Favre Reports Significant Parkinson's Medication Reduction as Zhittya Genesis Medicine Marks Four Years of Parkinson’s Research
14/05/2026
The three-time NFL MVP, Super Bowl XXXI Champion, and former Green Bay Packers quarterback says he has been treated twice with Zhittya's investigational biologic and has "significantly" reduced his dopamine medication [...]
Zealand Pharma - Transactions related to share buy-back program (weeks 19-20, 2026)
14/05/2026
Company announcement No. 16 / 2026 Zealand Pharma - Transactions related to share buy-back program (weeks 19-20, 2026) Copenhagen, Denmark, May 14, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: [...]
ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31st, 2026
14/05/2026
Updated positive data from iadademstat in 1L AML unfit patients to be presented at EHA, with 100% ORR, 93% CRc and 79% strict CR at abstract submission cut-off Positive updated data from iadademstat in relapsed/ [...]
Rarecells Recognized Among Top 5 Disruptive Health Technologies with the Potential to Change the World by Maynooth University’s Innovation Value Institute
14/05/2026
NEW YORK and PARIS, May 14, 2026 (GLOBE NEWSWIRE) -- Rarecells, a pioneer in liquid biopsy technologies for early cancer detection, today announced that its proprietary ISET® diagnostic system has been recognized by the [...]
Imviva Biotech Presents Data Demonstrating Durable Clinical Responses from Ongoing Phase 1/2 Study of CTA313 in Systemic Lupus Erythematosus at ASGCT 2026
14/05/2026
100% of patients treated with CTA313 achieved an SRI-4 response, with half achieving remission BOSTON, May 14, 2026 (GLOBE NEWSWIRE) -- Imviva Biotech, a clinical-stage biotechnology company developing next-generation [...]
Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
14/05/2026
Company plans to submit a Biologics License Application (BLA) for aglatimagene besadenovec (aglatimagene or CAN-2409) in localized, intermediate- to high-risk prostate cancer in Q4 2026 Announced purpose-built [...]
Benitec Biopharma Releases Third Quarter 2026 Financial Results and Provides Operational Update
14/05/2026
Late-breaking abstract for BB-301 presented at the Muscular Dystrophy Association (MDA) Clinical and Scientific Conference in March demonstrated durable responses to low dose BB-301 at 12-months and 24-months post- [...]
INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease
14/05/2026
BOCA RATON, FL, May 14, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB), a late-stage biotechnology company focused on inflammation and immunology, today announced that the U.S. Food and Drug Administration (FDA [...]

Pages